Mary Scott Roberts, MD

Vice President
BridgeBio Pharma
San Francisco, United States

Disclosure information not submitted.

Presentation(s):

• MON-761 - Genetic Testing of over 400 Individuals with Non-Surgical Hypoparathyroidism Shows Gain-of-Function CASR Variants as the Most Common Genetic Cause Identified

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT